Commenting today on the Centers for Medicare & Medicaid Services鈥 proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2020, AHA said it generally supports the reforms to update the payment system, but expressed concern with the substantial redistribution of cases under the payment model proposed for FY 2020. The comment letter raises concerns regarding the FY 2020 case-mix system reforms finalized in last year鈥檚 rulemaking, as well as proposed changes to quality outcomes reporting and patient assessments. 鈥淸W]e remain concerned that these new policies are, in part, based on unreliable data and that the proposed rule lacks adequate detail and transparency,鈥 AHA wrote. 鈥淲e also are concerned that the proposed rule lacks the patient-level and cost data needed to replicate the model for the purpose of evaluating its impact to consider whether alternatives would be warranted. These issues deserve further discussion and transparency in the final rule to allow the field to best prepare for the changes and serve their patients.鈥

Related News Articles

Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress鈥 formula for鈥
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize鈥
Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation鈥
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from鈥
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state鈥檚 law protecting 340B pricing for contract pharmacy arrangements. The鈥
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥